Success Metrics

Clinical Success Rate
100.0%

Based on 18 completed trials

Completion Rate
100%(18/18)
Active Trials
0(0%)
Results Posted
17%(3 trials)

Phase Distribution

Ph phase_2
2
10%
Ph phase_3
3
15%
Ph phase_1
15
75%

Phase Distribution

15

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution20 total trials
Phase 1Safety & dosage
15(75.0%)
Phase 2Efficacy & side effects
2(10.0%)
Phase 3Large-scale testing
3(15.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

94.7%

18 of 19 finished

Non-Completion Rate

5.3%

1 ended early

Currently Active

0

trials recruiting

Total Trials

20

all time

Status Distribution
Completed(18)
Terminated(1)
Other(1)

Detailed Status

Completed18
unknown1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
20
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 115 (75.0%)
Phase 22 (10.0%)
Phase 33 (15.0%)

Trials by Status

unknown15%
withdrawn15%
completed1890%

Recent Activity

Clinical Trials (20)

Showing 20 of 20 trials
NCT06717269Phase 1

A Single and Multiple Ascending Doses, Relative Bioavailability, Food Effect, and Drug-Drug Interaction Study of NX-5948 in Healthy Volunteers

Completed
NCT06704763Phase 1

A Drug-Drug Interaction Study of Orforglipron (LY3502970) With Quinidine in Healthy Participants

Completed
NCT05444556Phase 1

A Study of Imlunestrant (LY3484356) in Female Healthy Participants

Completed
NCT06493409Phase 1

A Study to Assess the Effect of Voriconazole and Quinidine on the Pharmacokinetics of a Single Dose of Repotrectinib in Healthy Participants

Completed
NCT06979388Phase 1

A Study to Investigate the Effect of Food on Balcinrenone/Dapagliflozin Pharmacokinetics in Fed and Fasted State and Pharmacokinetics of Balcinrenone When Dosed With a P-gp Inhibitor in Healthy Participants.

Completed
NCT06974565Phase 1

A Study to Investigate the Pharmacokinetics of AZD2389 in Healthy Participants When Administered Alone and in Combination With Quinidine

Completed
NCT06847464Phase 1

A Drug-Drug Interaction Study to Evaluate the Effects of Itraconazole, Carbamazepine, Quinidine and Fluconazole on the Pharmacokinetics and Safety of EDP-323.

Completed
NCT05593757Phase 2

Quinidine Versus Verapamil in Short-coupled Idiopathic Ventricular Fibrillation

Unknown
NCT05594602Phase 1

Drug-Drug Interaction Study Between EDP-235, Itraconazole, Carbamazepine and Quinidine in Healthy Subjects.

Completed
NCT04783753Phase 1

Drug-Drug Interaction Study Between EDP-514, Itraconazole, Carbamazepine, and Quinidine in Healthy Subjects

Completed
NCT00789165Phase 2

Empiric Quinidine for Asymptomatic Brugada Syndrome

Withdrawn
NCT01712828Phase 1

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

Completed
NCT03755778Phase 1

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

Completed
NCT03610945Phase 1

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Completed
NCT01460381Phase 1

A Study to Evaluate the Effect of Genotype on LY2216684

Completed
NCT00000556Phase 3

Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM)

Completed
NCT00000518Phase 3

Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM)

Completed
NCT01533155Phase 1

Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118

Completed
NCT02171624Phase 1

Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate

Completed
NCT00000464Phase 3

Cardiac Arrest in Seattle: Conventional Versus Amiodarone Drug Evaluation (CASCADE)

Completed

All 20 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
20